Collectively the analysis shows that alterations in PTEN that could drive PTEN protein loss or deficiency are common in ER+ BC biopsies with PIK3CA mutations, with hemizygous deletion frequency of ~18–25% and homozygous deletions being less common at frequency of ~3–9%. Here, PTEN is linked to breast cancer.